VIMENTIN EXPRESSION IN CIRCULATING TUMOR CELLS AS A PROGNOSTIC BIOMARKER FOR BREAST CANCER PROGRESSION

Saumya Surekha, Anurag Kuhad, Vijay Pratap Singh, Chandan Kumar Singh

Abstract


Circulating tumor cells (CTCs) play a critical role in cancer metastasis. Vimentin, an intermediate filament protein and a hallmark of epithelial-tomesenchymal
transition (EMT), is implicated in cancer progression and dissemination. This study aimed to evaluate vimentin gene expression in
CTCs as a potential prognostic biomarker for breast cancer. Peripheral blood samples were collected from 30 patients with histologically
confirmed breast cancer and 20 age-matched healthy controls. CTCs were isolated using Ficoll-Paque density gradient centrifugation. Following
initial separate on, a negative selection approach was employed using CD45-conjugated magnetic beads to deplete leukocytes, thereby enriching
the CTC population. Vimentin mRNA expression was quantified by reverse transcription quantitative PCR (RT-qPCR). Vimentin expression was
significantly upregulated in CTCs from breast cancer patients compared to healthy controls (p < 0.01). Elevated expression levels were positively
associated with advanced tumor stage (stage III/IV) and adverse clinical outcomes. Vimentin gene expression in CTCs is a potential non-invasive
biomarker for predicting breast cancer progression. Its prognostic value may assist in tailoring personalized treatment strategies. Future studies
should validate these findings in larger cohorts and explore the mechanistic role of vimentin in breast cancer metastasis


Keywords


Circulating Tumor Cells, Vimentin, Breast Cancer, Biomarker

Full Text:

PDF

References


Gupta, S. D., Sen, A., Priyadarshi, P., & Ta, M. J. S. p. (2023). Enzyme-free isolation of

mesenchymal stem cells from decidua basalis of the human placenta. 4(3), 102498.

Ho, A.-S., Chang, J., Lee, S.-D., Sie, Z.-L., Shih, H.-F., Yeh, C., . . . Cheng, C.-C. J. S. R.

(2024). Nucleos (t) ide analogues potentially activate T lymphocytes through inducing interferon expression in hepatic cells and patients with chronic hepatitis B. 14(1), 25286.

Hu, L., Chen, X., Chen, M., Fang, J., Nie, J., & Dai, H. J. B. L. (2021). Enrichment and

detection of circulating tumor cells by immunomagnetic beads and flow cytometry. 43,

-34.

Kaller, M., Forné, I., Imhof, A., & Hermeking, H. J. C. (2024). LINC01021 Attenuates

Expression and Affects Alternative Splicing of a Subset of p53-Regulated Genes. 16(9),

Li, H., Zhu, Y.-Z., Xu, L., Han, T., Luan, J., Li, X., . . . Research, C. C. (2024). Exploring

new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells

and a promising therapeutic target in advanced gastric Cancer. 43(1), 129.

Li, J., Goh, E. L., He, J., Li, Y., Fan, Z., Yu, Z., . . . Liu, D.-X. J. B. (2023). Emerging

intrinsic therapeutic targets for metastatic breast cancer. 12(5), 697.

Noubissi Nzeteu, G. A., Geismann, C., Arlt, A., Hoogwater, F. J., Nijkamp, M. W.,

Meyer, N. H., & Bockhorn, M. J. C. (2022). Role of epithelial-to-mesenchymal

transition for the generation of circulating tumors cells and cancer cell dissemination.

(22), 5483.

Sarhadi, V. K., & Armengol, G. J. B. (2022). Molecular biomarkers in cancer. 12(8),

Sathishkumar, K., Sankarapillai, J., Mathew, A., Nair, R. A., Gangane, N., Khuraijam,

S., . . . Deshmane, V. J. C. (2024). Breast cancer survival in India across 11 geographic

areas under the National Cancer Registry Programme. 130(10), 1816-1825.

Xie, X., Wang, L., Wang, X., Fan, W.-H., Qin, Y., Lin, X., . . . Li, S. J. F. i. O. (2021).

Evaluation of cell surface vimentin positive circulating tumor cells as a diagnostic

biomarker for lung cancer. 11, 672687.

Zhao, P., Zhou, W., Liu, C., Zhang, H., Cheng, Z., Wu, W., . . . Zhang, Y. J. J. o. C. (2019).

Establishment and characterization of a CTC cell line from peripheral blood of breast

cancer patient. 10(24), 6095.


Refbacks

  • There are currently no refbacks.